J Clin Invest 1996;98:11016
The challenge shifts from physical symptoms to emotional adjustment, accepting plateau and planning for long-term maintenance
In a sub-analysis of more than 300 participants from a large clinical trial, individuals regained, on average, two-thirds of the weight they had lost within one year of stopping the medication
Emerging trials are assessing the efficacy of GLP-1s in modulating neuroinflammation to potentially treat neurodegenerative diseases like Parkinsons and Alzheimers
The participant in the semaglutide 1.0 mg arm completed treatment
Several meta-analyses suggest a reduced incidence of gestational diabetes with this dosing strategy, but authors emphasize that evidence quality is moderate and that further large-scale randomized trials are needed before universal recommendations can be made.9 24 25 26 Psychiatric research (high-dose, limited evidence) Studies exploring inositol for panic disorder, obsessive-compulsive disorder, or depression have used much higher doses often 12,00018,000mg per day.35 36 37 While some small trials reported symptom improvement, results have been inconsistent, and these doses are far higher than those used for metabolic or reproductive purposes.38 Most reviews do not recommend high-dose inositol for mental health outside of clinical supervision.42 Across contexts, higher doses do not consistently produce stronger effects
.png)
